Non-Small Cell Carcinoma — Trials

Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6,756 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,752
Recruiting: 926
Ph III recruiting: 138
Growth YoY: +3.1%
Industry share: 44%
Top sponsor: AstraZeneca
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,045)

clinicaltrialsPublishedShowing 851–860 of 860 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00585845	Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment	terminated	Phase 1	17	Anza Therapeutics, Inc.INDUSTRY	2	Feb 20, 2009	clinicaltrials
NCT00161278	Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling	terminated	Phase 2	1	University of Michigan Rogel Cancer CenterOTHER	1	Jul 30, 2008